Fig. 1
From: DEPDC1B collaborates with GABRD to regulate ESCC progression
DEPDC1B is overexpressed in ESCC and correlates with poor prognosis. A Expression of DEPDC1B was performed based on the 161 tumor and 11 normal samples in the Cancer Genome Atlas (TCGA) database. B The correlation between DEPDC1B expression level and tumor stage was analyzed based on TCGA-ESCA database. C The expression level of DEPDC1B in ESCC was verified based on the tissue microarrays (tumor, n = 266; normal, n = 39) from clinical ESCC patients using immunohistochemical (IHC). D The correlation between DEPDC1B and survival of ESCC patients (n = 266) was analyzed by Kaplan–Meier method